Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?

Johnson, Miriam; Johnson, M.; Maraveyas, A.

Abstract

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is still limited. Limitations can be related to the thromboembolism itself, the underlying cancer, or to the management process. There is significant literature that deals with the first two, but very little regarding the systems we use, or how the inadequacies in documentation, identification and classification of VTE affect the cancer patients themselves. This review aims to raise awareness of this neglected area and stimulate research that may lead to improvements in patient care

Citation

Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?. The British Journal of Cancer, 100(12), 1837-1841. https://doi.org/10.1038/sj.bjc.6605091

• Journal Article Type: Article
• Acceptance Date: Apr 23, 2009
• Online Publication Date: Jun 2, 2009
• Publication Date: Jun 16, 2009
• Journal: Br.J.Cancer
• Print ISSN: 0007-0920
• Electronic ISSN: 1532-1827
• Publisher: Nature Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 100
• Issue: 12
• Pages: 1837-1841
• DOI: https://doi.org/10.1038/sj.bjc.6605091
• Keywords: classification; Disease; epidemiology; Morbidity; mortality; Research; Thromboembolism
• Public URL: https://hull-repository.worktribe.com/output/423565